Somatic Mutation clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for

  • UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations

    Sorry, not yet accepting patients

    This is a non-therapeutic clinical research biorepository protocol designed to obtain, store, and clinically annotate biospecimens from participants with hereditary cancers. Those biospecimens will be used to generate participant-derived tumor models that will serve as a resource to better understand hereditary cancers and develop new efficient therapies.

    San Francisco, California

Our lead scientists for Somatic Mutation research studies include .

Last updated: